Change in Management

Pfizer Limited The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274 September 18, 2026 The Corporate Relationship Dept. The Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1st Floor, P.J.Towers Exchange Plaza, 5th Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER Dear Sirs / Madam, Sub: Intimation regarding change in Senior Management Personnel of the Company. Ref.: Regulations 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that Mr. Sharad Goswami, Senior Director – Policy & Public Affairs has resigned from the services of the Company with effect from September 25, 2026 (close of business), to pursue opportunities outside Pfizer Limited. Mr. Goswami shall accordingly cease to be a Senior Management Personnel, effective the said date. The additional details required to be disclosed pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed as Annexure – A & Annexure – B. Request you to please take the above on record. Thanking you, Yours truly, For Pfizer Limited Prajeet Nair Director – Corporate Services & Company Secretary CIN: L24231MH1950PLC008311 Email ID: contactus.india@pfizer.com Website: www.pfizerltd.co.in Annexure - A Additional information pursuant to SEBI Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Sr. Particulars Description 1. Reason for change viz. appointment, re- Resignation of Mr. Sharad Goswami, appointment, resignation, removal, Senior Director – Policy & Public Affairs death or otherwise. with effect from September 25, 2026 (close of business) to pursue opportunities outside Pfizer Limited. 2. Date of appointment / cessation Cessation as Senior Director – Policy & (as applicable) & term of appointment, Public Affairs with effect from re-appointment. September 25, 2026 (close of business). 3. Brief profile (in case of appointment) Not Applicable 4. Disclosure of relationships between Not Applicable directors (in case of appointment of a director). Annexure – B From: Goswami, Sharad Tarun <Sharad.Goswami@pfizer.com> Sent: Friday, September 18, 2026 2:39 PM To: Nevatia, Meenakshi <Meenakshi.Nevatia@pfizer.com> Cc: Parida, Reshma <Reshma.Parida@pfizer.com> Subject: Resignation September 18, 2026 Managing Director Pfizer Limited Mumbai. Dear Madam, Sub: Resignation I hereby tender my resignation from the services of the Company, e(cid:431)ective close of business on September 25, 2026, to pursue opportunities outside Pfizer. I would like to thank the management and colleagues for their support extended to me during my tenure with the Company. Yours truly, Sharad Goswami